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Abstract
Context—Recent analyses of epidemiological data including the National Health and Nutrition 
Examination Survey (NHANES) have suggested that the harmful effects of obesity may have 
decreased over calendar time. The shifting BMI distribution over time coupled with the application 
of fixed broad BMI categories in these analyses could be a plausible “nuisance contributor” to this 
observed change in the obesity-associated mortality over calendar time.
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Objective—To evaluate the extent to which observed temporal changes in the obesity-mortality 
association may be due to a shifting population distribution for body mass index (BMI), coupled 
with analyses based on static, broad BMI categories.
Design, Setting, and Participants—Simulations were conducted using data from NHANES I 
and III linked with mortality data. Data from NHANES I were used to fit a “true” model treating 
BMI as a continuous variable. Coefficients estimated from this model were used to simulate 
mortality for participants in NHANES III. Hence, the population-level association between BMI 
and mortality in NHANES III was fixed to be identical to the association estimated in NHANES I. 
Hazard ratios (HRs) for obesity categories based on BMI for NHANES III with simulated 
mortality data were compared to the corresponding estimated HRs from NHANES I.
Main Outcome Measures—Change in hazard ratios for simulated data in NHANES III 
compared to observed estimates from NHANES I.
Results—On average, hazard ratios for NHANES III based on simulated mortality data were 
29.3% lower than the estimates from NHANES I using observed mortality follow-up. This 
reduction accounted for roughly three-fourths of the apparent decrease in the obesity-mortality 
association observed in a previous analysis of these data.
Conclusions—Some of the apparent diminution of the association between obesity and 
mortality may be an artifact of treating BMI as a categorical variable.
Keywords
obesity; mortality; simulations; BMI distribution and categories
Background
Because of the rapid increase in the prevalence of overweight and obesity in the United 
States,1,2 and the association of obesity with various diseases,3 there has been consistent 
research to quantify the public health impact of obesity, particularly with respect to 
mortality. In 2005, Flegal et al.,4 found a very interesting and, to our knowledge, novel result 
using data from the National Health and Nutrition Examination Surveys (NHANES). 
Specifically, they reported that the deleterious association of body mass index (BMI)-derived 
categories of overweight and obesity on mortality may have weakened over the last four 
decades or so. It can be speculated that such patterns of results may be due to medical 
advances in the treatment of obesity-related co-morbidities.
Results from other studies have been mixed. Using a prospective cohort from the Cancer 
Prevention Study II, Calle et al.5 found no indication that the relative mortality rates (MRs) 
associated with BMI-derived categories of overweight or obesity have decreased. In contrast, 
three recent studies provided supportive evidence that the deleterious association of obesity 
with mortality has diminished over time, at least in certain subpopulations.6–8 These diverse 
results have spurred considerable speculation as to whether methodological factors or data 
artifacts such as regression-dilution and reverse-causation may have influenced the 
findings.9–15 However, as discussed previously in Mehta et al. (2014), all of the studies 
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evaluating change in the obesity-mortality association are potentially confounded by 
unstable study-level factors.7
One potential distorting factor is the effect of categorizing BMI in the analysis coupled with 
a shifting population BMI distribution. BMI is often modeled as a categorical variable using 
cutoffs based on sample quantiles or predefined cut-points from federal guidelines.4,16 
Treating BMI as a categorical variable is one way of allowing for nonlinearity, and some 
find it easier to interpret and communicate findings from categorical analyses. In this study, 
we evaluate the effect of BMI categorization and a shifting population BMI distribution as a 
plausible “nuisance contributor,” using the same data from NHANES as in the study of 
Flegal et al.4 We use the term nuisance contributor in the sense of a nuisance statistical 
parameter, that is, an aspect of the model distribution that is not of primary interest, but must 
be accounted for. Specifically, we hypothesize that even if the true effect of BMI as a 
continuous variable has not changed, changes in the BMI distribution could affect the 
calculated estimates for specific BMI categories. Within each BMI category is a distribution 
of continuous BMI values. Those within-category distributions may have changed over time 
as the overall distribution of BMI has markedly changed over time.1,2,17,18 To the extent that 
different BMI values within a BMI category are associated with different MRs, then absolute 
categorical MRs, which would be functions of the absolute MRs integrated over the within-
category probability density function of BMI, can change over time even though the absolute 
rate associated with any specific value of BMI may not have changed.
Materials and Methods
Separate waves of a large publicly available complex cross-sectional health examination 
survey designed to represent the United States non-institutionalized civilian population were 
used. Both studies reported here used NHANES I (1971–1975) and III (1988–1994) baseline 
data. NHANES I Epidemiologic Follow-Up Study (NHEFS) (1982–84) was used to 
retrospectively impute smoking data.15,19 Design and sampling methods for NHANES I and 
NHANES III have been previously reported.20–22 Mortality information for NHANES I 
participants was obtained from the 1992 NHEFS Vital and Tracing Status file with follow-up 
until 1992.23,24 Mortality information for NHANES III was available from the NHANES III 
public-use National Center for Health Statistics (NCHS) linked mortality file with follow-up 
until 2000.
Adults aged 25 years and older at baseline were included in our analyses, and pregnant 
women were excluded.25 Our model and covariate coding reflected Flegal et al.’s4 including 
smoking, race, sex, and alcohol consumption as covariates. The smoking variable was coded 
as never, current, and former smokers and sex as male or female. Alcohol consumption 
categories were defined as 0, <0.07, 0.07 to 0.35, and ≥0.35 oz/d. Race was coded as 
“white,” “black,” or “other.” Our primary analysis models were conducted to account for the 
complex sampling design of NHANES as described elsewhere.26 Attained age at death or 
end of follow-up was chosen as the time scale,4,27 and left truncation at the age of study 
entry was accounted for in each survey Cox model. Publicly available mortality data were 
used to create 3 different attained age subpopulations (25 to <60, 60 to <70, and ≥70 years 
of age) for NHANES I and III. Before evaluating our hypothesis, we replicated the analysis 
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done by Flegal et al.4 to reproduce the hazard ratios (HRs) of the NHANES I and III 
subpopulations published in their Figure 1. This was important because analyzing NHANES 
data is complex and the choice of sample weights, variables, and derived variable coding can 
affect the analysis.15 R 2.7.228 and the R/survey package 3.1029 were used to perform all 
analyses.
A simulation procedure was used to evaluate the impact of shifting BMI distribution along 
with broad fixed BMI categories
Our simulation procedure was designed to assess the impact of applying broad static BMI 
categories by first estimating the BMI-mortality relationship in NHANES I. We then forced 
this relationship to hold in NHANES III by simulating mortality follow-up conditional on its 
observed baseline data, thus implying no change in the BMI-mortality relationship and yet 
allowing for a shifting population BMI distribution.
a. Fitting a ‘true’ model for NHANES I sub-population with BMI as a 
continuous predictor:
Within each attained age strata of NHANES I (e.g. age strata 25–<60) 
linked to the NHEFS mortality data, a Cox proportional hazards model 
was fit treating mean-centered BMI as a cubic polynomial. Race, sex, age, 
smoking status and alcohol consumption were included as covariates. To 
improve model fit, age was modeled as a quadratic polynomial.
b. Simulating survival times for NHANES III Subpopulation.
We applied the simulation procedure described in Bender et al.30,31 to 
approximate the baseline survival distribution from the Cox model. Within 
each NHANES I attained age strata, the baseline hazard was approximated 
by an exponential distribution. We simulated survival times for each 
NHANES III attained age strata, using the estimated parameters for the 
derived distribution and estimated coefficients of the predictors from the 
corresponding ‘true’ model with observed BMI and covariate data from 
corresponding sub-population of NHANES III (e.g. attained age strata 25–
<60).
c. Simulating right censoring and events (death).
In order to induce similar lengths of follow-up and patterns of right-
censoring within our simulations, we fit an analogous logistic regression 
model to the NHANES I dataset with whether or not death was observed 
as the outcome, using the same set of predictors included in the Cox 
regression model. Using the resulting estimates, we then inverted the 
logistic model to calculate predicted probabilities of observing the death 
time for each individual in NHANES III. Within each simulated data set, 
we randomly assigned each simulated mortality time as observed/censored 
according to this predicted probability. Moreover, individuals simulated to 
live longer than their assigned attained age subpopulation (based on 
observed mortality) were censored at the following attained age cutoffs: 
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59.9 for 25 to <60 and 69.9 for 60 to <70. We generated 2000 simulated 
mortality datasets for each attained age strata of NHANES III.
d. Evaluating the effect of shifting BMI distribution and categorical BMI 
variable in the model.
For each simulated attained age NHANES III data, a Cox proportional 
hazards model was then fit with BMI split into five categories based on 
recommendations from federal guidelines4 and described earlier. 
Percentile based confidence intervals for the HRs for each of these BMI 
categories of each sub-population for NHANES III were computed from 
the empirical distribution of the 2000 simulated datasets. Point estimates 
of the HRs from the simulated follow-up data were calculated as the 
medians of the empirical distributions of the log HRs. We then evaluated 
the percentage reduction in the HRs of grade 1 and 2/3 obesity in 
NHANES III by using simulated follow-up data with respect to the 
corresponding categories in NHANES I that could be attributed to this 
nuisance contributor.
Sensitivity Analyses
We performed additional simulations in the attained age category 25 to <60 as sensitivity 
analyses to evaluate the robustness of our findings with another parametric specification 
functional form used as a true model in NHANES I. We also conducted simulations to 
account for the uncertainty in the coefficients estimated from NHANES I. To assess the 
robustness of our findings to the functional form of the parametric model, we simulated 
mortality follow-up of NHANES III by choosing a penalized spline model using the 
‘pspline’ function (with degree=4) available in the survival package of R with degree=4. In 
these simulations we did not account for complex sampling design. Hence, we also 
recomputed the obesity category HRs in NHANES I and III using observed mortality 
follow-up without incorporating the complex sampling design. We then compared the HRs 
of obese categories from NHANES III simulated mortality follow-up with corresponding 
hazard ratios of obesity categories from NHANES I based on observed mortality follow-up.
Further, to account for uncertainty in the estimates, we generated bootstrap replicates of 
NHANES I data. We fitted the penalized spline parametric form and redid our simulations. 
That is, for each iteration of our simulation in these analyses, the true model was estimated 
from a bootstrap replicate of NHANES I. The observed mortality-follow-up based HRs of 
obese categories for bootstrap replicates of NHANES I were estimated and compared to 
corresponding hazard ratios in NHANES III using simulated mortality.
Results
Descriptive measures of NHANES I and NHANES III can be found in Table 1. These 
descriptive measures illustrate that our baseline data was very similar to the published 
analyses of Flegal et al. There were 3,773 deaths observed for NHANES I from an 
unweighted sample size of 13,551 and 2,793 deaths observed for NHANES III from an 
unweighted sample size of 14,985. There is an increase in the prevalence of overweight, 
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grade 1 obesity, and grade 2/3 obesity moving from NHANES I to NHANES III. As seen in 
panels A and B of Figure 1 the BMI distribution has shifted from the 1970s (NHANES I) to 
1990s (NHANES III).
Changes in obesity-associated mortality using observed mortality data
The HRs estimated for the different subpopulations of NHANES I and III by use of the 
NCHS linked mortality files (observed mortality) are shown in Figure 2 A, B, and C. In 
general, these results were similar to the findings published previously 4 where it was 
suggested that the deleterious effects of overweight and obesity on mortality have reduced 
over calendar time.
In the attained age stratum of 25 to <60 years, the percentage reduction in the HRs for grade 
1 and 2/3 obesity of NHANES III versus NHANES I were 26.28% and 52.33%, 
respectively. The interval estimates for grade 1 and grade 2/3 obesity in NHANES I were 
1.56 (1.02, 2.38) and 3.42 (2.02, 5.8). Corresponding estimates for NHANES III were 1.15 
(0.59, 2.24) and 1.63 (0.89, 2.98). In the attained age stratum of 60 to <70 years, the 
percentage reduction in the HRs of grade 1 and 2/3 obesity were 47.12% and 17.34% 
respectively. The HR estimates for grade 1 obesity were 1.74 (1.21, 2.49) for NHANES I 
and 0.92 (0.54, 1.56) for NHANES III. The HRs for grade 2/3 obesity were 1.96 (1.22, 3.15) 
and 1.62 (0.80, 3.29) in NHANES I and III respectively. In the attained age stratum of 70 
years or more, the percentage reduction in the HRs of grade 1 and 2/3 obesity were 28.57% 
and 49.73%, respectively. The HR of grade 1 obese in NHANES I was 1.26 (1.05, 1.51) and 
0.90 (0.74, 1.11) in NHANES III. The HR for grade 2/3 obese in NHANES I was 1.89 (1.40, 
2.55) and in NHANES III was 0.95 (0.65, 1.38).
BMI Categorization and Shifting BMI Distributions
We next generated HRs for NHANES III corresponding to different attained age strata from 
the simulated follow-up data so that the true association of BMI with mortality was forced to 
be the same as what was estimated in NHANES I. The HR point estimates for NHANES III 
are median values from the empirical distribution. Except for the underweight category in 
the attained age stratum of 25 to <60 years, the mean HR estimates from the empirical 
distribution were very similar to the median HR estimates of the empirical distribution 
(Figure 3 A, B, and C). This figure also includes the HRs for NHANES I computed from the 
publicly available NHEFS linked mortality data.
As shown in Figure 3A, for the attained age stratum of 25 to <60 years, grade 1 obesity in 
NHANES III had a HR of 1.0 (0.43, 2.01) while grade 2/3 obesity had a HR of 2.43 (1.21, 
4.81). The percentage reduction in the HR for grade 1 obesity in NHANES III with the 
simulated follow-up data versus the NHANES I HR with observed mortality follow-up was 
35.58%, with a similar relative reduction for grade 2/3 obesity (28.87%). These reductions 
were 135.40% and 55.16% of the corresponding decreases estimated using the observed 
mortality data for NHANES III.
As shown in Figure 3B, for the attained age stratum of 60 to <70 years, the percentage 
reduction in the HR for grade 1 obesity of NHANES III with the simulated follow-up data 
versus NHANES I was 32.23%, with a reduction of 10.87% for grade 2/3 obesity. This 
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reduction was 68.61% and 62.66% of the decrease found in the HRs of NHANES III using 
the observed NHANES III mortality data. The HR estimate for grade 1 obesity and grade 2/3 
obesity in NHANES III with simulated mortality data was 1.17 (0.49, 2.63) and 1.74 (0.57, 
4.08) respectively.
For the attained age stratum of ≥70 years, the percentage reduction in the HR of grade 1 
obesity of NHANES III with the simulated follow-up data versus NHANES I was 27.47%, 
with a reduction of 40.60% for grade 2/3 obesity. This reduction was 96.16% and 81.64% of 
the decrease found in the HR estimates of NHANES III by using the observed mortality 
data. The HR associated with grade 1 obesity and grade 2/3 obesity in NHANES III with 
simulated mortality data was 0.91 (0.75, 1.1) and 1.12 (0.86, 1.46) respectively.
Sensitivity Analyses
Table 2 provides the complete set of sensitivity analyses results. As expected the HR 
estimates of obese categories in NHANES I and III using observed mortality follow-up but 
without accounting for the complex sampling design were different than the estimates that 
were generated using the complex sampling design. However, the original pattern of obesity 
category hazard ratios still showed a decline from NHANES III to I. The first set of 
sensitivity analysis focused on understanding the robustness of our findings to the choice of 
the functional form of the parameters in the model. When a penalized spline model was 
fitted as true model to NHANES 1 and mortality follow-up simulated for NHANES III in 
attained age 25 to <60, the percentage reduction in the HR for grade 1 obesity in NHANES 
III with the simulated follow-up data versus the NHANES I HR with observed mortality 
follow-up was 31.85%. The percentage reduction for grade 2/3 obesity in NHANES III 
compared to NHANES I was 63.44%.
In the second set of sensitivity analysis we incorporated the uncertainty in the true model 
estimates from NHANES I by fitting the penalized spline model to NHANES I bootstrap 
replicates. We found that the percentage reduction in the HR for grade 1 obesity in 
NHANES III with the simulated follow-up data versus the NHANES I HR with observed 
mortality follow-up was 25.93%. The percentage reduction for grade 2/3 obesity in 
NHANES III compared to NHANES I was 66.9%.
Discussion
Changes observed in the obesity-mortality association have been attributed to medical 
advances in the treatment of obesity-related co-morbidities over calendar time.4,6,7,32 
However, all of the previous studies that have indicated a decline are potentially confounded 
by unstable study-level confounders.7 One such confounder discussed here is a shifting 
population BMI distribution coupled with analyses based on static, broad BMI categories. 
We used the widely cited nationally representative study by Flegal et al. to illustrate the 
influence of this nuisance contributor in studies evaluating changes in obesity-associated 
mortality over time.4 Because we simulated follow-up data for NHANES III such that the 
relationship between BMI and mortality was identical to that in NHANES I, the expectation 
is that the point estimates for each BMI categories in the respective attained age subgroup of 
the NHANES series would be similar. In other words, if the population BMI distribution had 
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no influence, we would not see lower HRs for the grade 1 and grade 2/3 obesity over 
calendar time. The results shown in Figure 3 indicate that in all attained age subgroups, the 
grade 1 and 2/3 obesity HRs for NHANES III from the simulated follow-up data were lower 
than what was estimated in NHANES I. In general, the decreases in the HR of NHANES III 
compared with NHANES I were very similar to the patterns seen in Figure 2, in which the 
public mortality data for NHANES III were used. On average, the HRs of NHANES III 
from simulated mortality follow-up were approximately 29.3% lower than the NHANES I 
estimates using observed mortality-follow-up. Overall, this trend suggests that the effect of 
BMI categorization and altered population BMI distributions between NHANES I and III 
may have contributed up to 75% of the apparent change in the obesity-mortality association 
over calendar time.
Replicating previously published work is a challenge, especially for complex data sets like 
NHANES.15,33 We recognize that analyzing the NHANES data correctly involves choosing 
variables appropriately, and we made an earnest effort to replicate the NHANES analyses 
according to the NCHS guidelines. While to the best of our knowledge we used the same 
exclusion criteria as that of the 2005 manuscript by Flegal et al.,4 we did notice a 
discrepancy in the unweighted sample size of NHANES I we derived compared to what has 
been published in 2005. One aspect of data merging specific to NHANES I that could have 
led to these different sample sizes was the use of NHANES I Epidemiologic Follow-Up 
Study (NHEFS) (1982–84) to retrospectively impute smoking data. While we replicated this 
step, there may have been additional data steps/details unknown to us limiting our ability to 
replicate their dataset. However, we want to stress that we used Flegal’s influential analysis 
as an illustration only to evaluate the role of plausibility of the nuisance contributor 
(unstable study-level confounder) since this was one of the first studies that showed 
significant declines in the obesity-associated mortality across period. Overall, our results for 
NHANES III were very similar to those published in 2005.4 Our results for the NHANES I 
data followed the overall trend, and most of the estimates were comparable to those 
previously published.4 However, a few point estimates of certain NHANES I BMI categories 
differed by more than 10%.
To verify our data, we reproduced the results published in Table 3 (HR estimates with 
baseline and retrospective smoking data) of Flegal et al. 2010.15 Because the results 
published for NHANES I in 201015 did not include alcohol in the model, we speculate that 
the variability between our results and those of Flegal et al.4 for the NHANES I data may be 
attributed to differences in the coding of the alcohol consumption covariate, as well as any 
perturbation introduced from using the publicly available mortality data. As illustrated in 
Figure 2, compared with NHANES I, in which the baseline data were collected in 1971–
1975, the HR of death in NHANES III for overweight and obesity was lower or equal across 
all attained age subpopulations. In general, these trends were similar to the findings 
published previously,4 where it was suggested that the deleterious effects of overweight and 
obesity on mortality have reduced over calendar time. Recent studies have indicated a 
similar trend at least for the certain subpopulations of the US population.
One of the limitations of our simulations is that our true model for NHANES I was 
estimated, and does not fully explain the variability in that dataset. Therefore, the reduction 
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in the HR of NHANES III (in Figure 3) estimated using simulated follow-up data may in 
part be a function of the choice of estimated model and the parametric approximation used 
to model the baseline hazard distribution. Our sensitivity analyses, however, assessed the 
robustness of our findings by assuming a different, much more flexible functional form of 
the parametric approximation as well as accounting for the uncertainty in the estimates. The 
overall trends of our findings were similar even when we switched from a cubic polynomial 
to a penalized spline approach and later accounted for the uncertainty in the estimates of the 
true model. Although we were not able to incorporate the complex sampling design when 
fitting the penalized spline model, interestingly, this limitation in the sensitivity analyses 
helped us assess whether our findings are sensitive to complex sampling design. However, 
we caution readers that the HR estimates of NHANES presented in the sensitivity analyses 
should not be considered estimates for the US population since the complex sampling design 
was not used.
Another complexity in our simulation stems from the attained age stratification as a means 
of addressing violations of proportional hazards assumption by stratifying on attained age 
when age is the time scale.27 This type of modeling implied that if the simulated follow-up 
of a NHANES III subject belonging to the original age stratum of 25 to <60 was death at 69, 
then our simulation procedure censored this individual at 59.9 years of age. If we chose not 
to follow this procedure, we would not be analyzing the simulated data and the observed 
data consistently. This mutually exclusive situation was a challenge to handle and may lead 
to some confounding in our simulations, especially in the age stratum of 25 to <60. 
However, this confounding was minimal or none in the age stratum of ≥70, for which we 
also found large effects that could be attributed to a shifting population BMI distribution.
In brief, our simulations based on an existing analysis in the literature suggest that the 
attenuation of the obesity-mortality association may in part be a function of treating BMI as 
a categorical variable combined with a change in the US population BMI distribution. One 
likely implication of this finding is that were the relationship in the NHANES data estimated 
using a parametric form such as a cubic polynomial or other flexible continuous functional 
form in a parametric survival regression, it is plausible that that the marginal effects at any 
BMI would be much closer for the two surveys than if BMI is categorized. The implications 
of our findings are not limited to the outcome of mortality. This phenomenon could also 
influence findings on the association of obesity with other outcomes such as disability.34 
Because obesity-mortality analyses can influence obesity-related clinical practice and public 
health policy, the identification of these nuisance contributors is potentially of great 
importance. We recommend supplementing categorical analyses by also treating BMI as a 
continuous variable in future BMI-mortality analyses, especially those assessing changes in 
the relationship over calendar time. Further, we advise caution in interpreting the apparent 
reduction in the obesity-mortality association as being driven by treatment advances. Future 
work in this area also needs to quantify rigorously the extent to which successes in medicine 
explain the any apparent reduction in the obesity-mortality association.
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Figure 1. Changes in BMI Distribution over Time Illustrated using NHANES I and NHANES III
BMI on the x-axis and density on the y-axis.
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Figure 2. Hazard Ratios (with 95 % confidence intervals) of Mortality Rate by BMI Category for 
Different Attained Age Strata using the NCHS linked Publicly Available Mortality Data
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BMI categories on the x-axis are underweight (BMI < 18.5), normal weight (BMI 18.5 to 
<25), overweight (BMI 25 to <30), grade 1 obesity (BMI 30 to < 35), and grade 2/3 obesity 
(BMI ≥ 35).
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Figure 3. Hazard Ratios (with 95 % confidence intervals) of Mortality Rate by BMI Category for 
Different Attained Age Strata using Simulated Mortality Data for NHANES III. Estimates for 
NHANES I based on the observed NHEFS linked mortality data
BMI categories on the x-axis are underweight (BMI < 18.5), normal weight (BMI 18.5 to 
<25), overweight (BMI 25 to <30), grade 1 obesity (BMI 30 to < 35), and grade 2/3 obesity 
(BMI ≥35).
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Table 1
Descriptive measures of the NHANES I and III survey data
NHANES I NHANES III
Baseline years 1971–1975 1988–1994
Mortality follow-up 1992 2000
Unweighted sample sizes 13,551 14,985
Person years of follow-up 219,030 123,603
Number of women 7,537 7,888
Age (minimum, mean, maximum) (25, 48.98, 74) (25, 52.69, 90)
Number of deaths* 3,773 2,793
Prevalence of BMI level (%)
BMI <18.5 3.37 2.14
BMI 18.5 – <25 46.28 35.58
BMI 25 – < 30 33.47 35.82
BMI 30 – <35 12.07 16.9
BMI ≥35 4.81 9.57
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